Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H16N2O |
| Molecular Weight | 192.2575 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)N2CCNCC2
InChI
InChIKey=MRDGZSKYFPGAKP-UHFFFAOYSA-N
InChI=1S/C11H16N2O/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3
| Molecular Formula | C11H16N2O |
| Molecular Weight | 192.2575 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action. | 2015-12 |
|
| Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry. | 2010-10-01 |
|
| 4-(4-Methoxy-phen-yl)piperazin-1-ium chloride. | 2009-02-11 |
|
| The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. | 2007-03-22 |
|
| Metabolism of designer drugs of abuse. | 2005-06 |
|
| In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. | 2004-02 |
|
| Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. | 2003-12-25 |
|
| Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. | 2003-06 |
|
| Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. | 2001-09-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:40:48 GMT 2025
by
admin
on
Mon Mar 31 23:40:48 GMT 2025
|
| Record UNII |
P385M92GYG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-Methoxyphenylpiperazine
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P385M92GYG
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY | |||
|
PARA-METHOXYPHENYLPIPERAZINE
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY | |||
|
DTXSID30191591
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY | |||
|
253-829-7
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY | |||
|
269722
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY | |||
|
38212-30-5
Created by
admin on Mon Mar 31 23:40:48 GMT 2025 , Edited by admin on Mon Mar 31 23:40:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
